Autopsy report · NCT03029611

IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery

“Terminated due to lack of funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 2 years 8 months before it stopped.
• 11 participants enrolled.
• Results were posted on the registry 2 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Washington

Sponsor type

University, hospital or other

Conditions

Stage III Fallopian Tube Cancer; Stage III Ovarian Cancer; Stage III Primary Peritoneal Cancer; Stage IIIA Fallopian Tube Cancer; Stage IIIA Ovarian Cancer; Stage IIIA Primary Peritoneal Cancer

Interventions

Carboplatin; Gynecological Surgical Procedure; Laboratory Biomarker Analysis; Paclitaxel; pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine

Participants

11

Sites

1

Countries

United States

Trials that died the same way

• Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
  “Terminated due to loss of funding” (95% match in meaning)
• Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
  “Terminated due to insufficient funding” (94% match in meaning)
• Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
  “Terminated due to loss in funding” (91% match in meaning)
• The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
  “Funding was terminated” (87% match in meaning)
• Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
  “Terminated because of slow recruitment and lack of funding support” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.